Coronary artery bypass grafting in patients with hematological neoplasms
CABG can be performed safely in most patients with stable hematological neoplasms, with no perioperative mortality, providing an opportunity for further hematological treatments. Preoperative blood cell levels significantly influence prognosis, underscoring the importance of multidisciplinary management. Larger studies are needed to validate these findings and refine treatment strategies.
Authors
- Zeye Liu (ORCID: https://orcid.org/0009-0000-8607-5406)
- Lixue Zhang (ORCID: https://orcid.org/0000-0003-3430-4988)
- Bo Lian (ORCID: https://orcid.org/0000-0001-6040-8022)
- Jian Liu (ORCID: https://orcid.org/0000-0001-9652-0198)
- Yi Shi (ORCID: https://orcid.org/0000-0002-0386-9022)
- Qing Gao (ORCID: https://orcid.org/0000-0002-5806-3974)
- S. Zhang (ORCID: https://orcid.org/0000-0001-5850-9502)
- Hao Jiang (ORCID: https://orcid.org/0009-0009-9296-6067)
Institutions
- Peking University (CN)
- Peking University People's Hospital (CN)
Publication Details
- Journal
- Frontiers in Cardiovascular Medicine
- Published
- 2025-12-17
- DOI
- https://doi.org/10.3389/fcvm.2025.1697389
- Primary Topic
- Cardiac and Coronary Surgery Techniques
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Peking University
- Peking University People's Hospital